GLOBAL DNA NANOTECHNOLOGY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Market News

Recent Developments:

New product launches & Approval:

In August 2020, Harvard University announced that Torus Biosystems TM, Inc., a biotechnology company which develop and commercialize DNA nanotechnology. The technology has the potential to disrupt current infectious disease diagnostics by delivering quantitative DNA and RNA results at the patient point-of-care in under 30 minutes.

Acquisition, Collaboration and partnerships:

In July 2022, SomaLogic Operating Co., Inc., a leader in proteomics technology, announced the acquisition of Palamedrix, Inc., an innovator in DNA nanotechnology. Palamedrix provides deep scientific and engineering expertise, miniaturization technology, and enhanced ease-of-use capabilities that SomaLogic intends to leverage as it develops the next generation of the SomaScan Assay. The acquisition brings two leading technologies together, which SomaLogic believes will accelerate SomaScan Platform utilization in global biopharma and academic markets, as well as in the emerging proteomic diagnostics space.

In June 2021, Danaher Corporation,  a biotechnology company, announced acquisition of Aldevron, a manufacturer of high-quality plasmid DNA, mRNA, and proteins, serving biotechnology and pharmaceutical customers across research, clinical, and commercial applications.

In May 2021, Ginkgo Bioworks, Inc., the organism company, announced acquisition of Dutch DNA Biotech B.V., a company focused on the development of fungal strains and fermentation processes for the production of proteins and organic acids, to broaden Ginkgo Bioworks, Inc.’s, platform for cell programming.